Allylmorpholine → N-[3-(3-Morpholin-4-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide

HRID 557307

Reaktionsgleichung

Reaktionsgleichung von HRID 557307
[CH2:1]([N:4]1[CH2:9][CH2:8][O:7][CH2:6][CH2:5]1)[CH:2]=[CH2:3].Br[C:11]1[CH:12]=[C:13]([NH:21][C:22](=[O:24])[CH3:23])[CH:14]=[C:15]([C:17]([F:20])([F:19])[F:18])[CH:16]=1.N1(CCCC2C=C(NC(=O)C)C=C(C(F)(F)F)C=2)CCCCC1>>[N:4]1([CH2:1][CH2:2][CH2:3][C:11]2[CH:12]=[C:13]([NH:21][C:22](=[O:24])[CH3:23])[CH:14]=[C:15]([C:17]([F:18])([F:19])[F:20])[CH:16]=2)[CH2:9][CH2:8][O:7][CH2:6][CH2:5]1

Komponenten

4

Edukt 3

HCID 136522AllylmorpholineHCID 21959349N-[3-bromo-5-(trifluoromethyl)phenyl]acetamideHCID 21959446N-[3-(3-Piperidin-1-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide

Produkt 1

HCID 21959489N-[3-(3-Morpholin-4-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide

Versuchsvorschrift

N-[3-(3-Morpholin-4-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide was prepared from allyl morpholine and N-(3-bromo-5-trifluoromethyl-phenyl)-acetamide similar to that described in the preparation of N-[3-(3-piperidin-1-yl-propyl)-5-trifluoromethyl-phenyl]-acetamide.

Quellen und Nachweise

ORD-Eintrag
ord-4a4eeaff391847f1819109b4217f2113
Quelldatensatz
uspto-grants-2011_11
Patentnummer
US08058445B2

Verknüpfte Notizen

Wird geladen…